- Home
- SGN vs NDRA Comparison
SGN vs NDRA Comparison
Compare SGN & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGN
- NDRA
- Stock Information
- Founded
- SGN 2019
- NDRA 2007
- Country
- SGN United States
- NDRA United States
- Employees
- SGN N/A
- NDRA N/A
- Industry
- SGN
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SGN
- NDRA Health Care
- Exchange
- SGN Nasdaq
- NDRA Nasdaq
- Market Cap
- SGN 4.1M
- NDRA 3.6M
- IPO Year
- SGN 2023
- NDRA 2017
- Fundamental
- Price
- SGN $2.25
- NDRA $6.01
- Analyst Decision
- SGN
- NDRA Strong Buy
- Analyst Count
- SGN 0
- NDRA 1
- Target Price
- SGN N/A
- NDRA $14,000.00
- AVG Volume (30 Days)
- SGN 254.0K
- NDRA 36.2K
- Earning Date
- SGN 11-14-2024
- NDRA 11-15-2024
- Dividend Yield
- SGN N/A
- NDRA N/A
- EPS Growth
- SGN N/A
- NDRA N/A
- EPS
- SGN N/A
- NDRA N/A
- Revenue
- SGN $576,488.00
- NDRA N/A
- Revenue This Year
- SGN N/A
- NDRA N/A
- Revenue Next Year
- SGN N/A
- NDRA N/A
- P/E Ratio
- SGN N/A
- NDRA N/A
- Revenue Growth
- SGN 147.76
- NDRA N/A
- 52 Week Low
- SGN $2.00
- NDRA $4.01
- 52 Week High
- SGN $47.52
- NDRA $2,240.00
- Technical
- Relative Strength Index (RSI)
- SGN 30.52
- NDRA 51.58
- Support Level
- SGN $2.00
- NDRA $5.60
- Resistance Level
- SGN $2.69
- NDRA $6.29
- Average True Range (ATR)
- SGN 0.32
- NDRA 0.60
- MACD
- SGN 0.15
- NDRA 0.02
- Stochastic Oscillator
- SGN 22.32
- NDRA 27.29
About SGN Signing Day Sports Inc.
Signing Day Sports Inc is a technology company developing and operating platforms aiming to allow significantly more student-athletes to go to college and continue playing sports. Its platform Signing Day Sports is a digital ecosystem to help athletes get discovered and recruited by coaches and recruiters across the country. It currently fully supports football and baseball, and it plans to expand the Signing Day Sports platform to include additional sports.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.